Paper6973612
Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391.
Tajima M and 4 others. J Gen Microbiol, 1980. Cited by 43 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391. Papers, record 6973612. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6973612
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Citrobacter | Major topic |
| beta-Lactamases | Major topic |
| Amino Acids | |
| Anti-Bacterial Agents | |
| Cephalosporinase | |
| Microbial Sensitivity Tests | |
| Neutralization Tests | |
| Penicillinase |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41801637 | From environmental reservoirs to clinical threats: the expanding resistome and genetic plasticity of Citrobacter spp. | Infection | 2026 | https://conductscience.org/library/papers/41801637 | PubMed |
| 36009210 | A Novel Disease (Water Bubble Disease) of the Giant Freshwater Prawn Macrobrachium rosenbergii Caused by Citrobacter freundii: Antibiotic Treatment and Effects on the Antioxidant Enzyme Activity and Immune Responses. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36009210 | PubMed |
| 12037047 | Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV beta-lactamases. | J Clin Microbiol | 2002 | https://conductscience.org/library/papers/12037047 | PubMed |
| 10991860 | Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10991860 | PubMed |
| 9420035 | In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9420035 | PubMed |
| 7793861 | Mechanism of tonB-dependent transport of KP-736, a 1,5-dihydroxy-4-pyridone-substituted cephalosporin, into Escherichia coli K-12 cells. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7793861 | PubMed |
| 7574506 | A functional classification scheme for beta-lactamases and its correlation with molecular structure. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7574506 | PubMed |
| 6808912 | Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6808912 | PubMed |
| 6610388 | Development of resistance to cephalosporins in clinical strains of Citrobacter spp. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6610388 | PubMed |
| 6350266 | Comparison of the overlapping frd and ampC operons of Escherichia coli with the corresponding DNA sequences in other gram-negative bacteria. | J Bacteriol | 1983 | https://conductscience.org/library/papers/6350266 | PubMed |
| 6301366 | Unusual mode of inhibition of Citrobacter freundii beta-lactamases by ceftriaxone. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6301366 | PubMed |
| 6269489 | Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6269489 | PubMed |
| 6100421 | In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6100421 | PubMed |
| 3890729 | In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3890729 | PubMed |
| 3879659 | Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3879659 | PubMed |
| 3264155 | A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds. | Biochem J | 1988 | https://conductscience.org/library/papers/3264155 | PubMed |
| 3264154 | A survey of the kinetic parameters of class C beta-lactamases. Penicillins. | Biochem J | 1988 | https://conductscience.org/library/papers/3264154 | PubMed |
| 2694954 | Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2694954 | PubMed |
| 2658787 | Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2658787 | PubMed |
| 2658786 | Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2658786 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6973612
GET https://conductscience.org/api/papers/v1/6973612/cited_by?page=2